Dosage Optimization of Efavirenz Based on a Population Pharmacokinetic–Pharmacogenetic Model of HIV-infected Patients in Thailand
© 2020 Elsevier Inc. Purpose: Efavirenz exhibits high interindividual variability in plasma concentrations, leading to unpredictable efficacy and toxicity. Polymorphism of CYP2B6 516G > T has been found to predominantly contribute to efavirenz variability. However, dosage recommendations incorpor...
Saved in:
Main Authors: | Piyawat Chaivichacharn, Anchalee Avihingsanon, Weerawat Manosuthi, Sasiwimol Ubolyam, Siraprapa Tongkobpetch, Vorasuk Shotelersuk, Baralee Punyawudho |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85085047562&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/70818 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis of tenofovir in Thai HIV-infected patients
by: Kanokrat Rungtivasuwan, et al.
Published: (2018) -
Pharmacogenetics-based population pharmacokinetic analysis for dose optimization of ritonavir-boosted atazanavir in Thai adult HIV-infected patients
by: Noppaket Singkham, et al.
Published: (2022) -
Population pharmacokinetics and dose optimisation of ritonavir-boosted atazanavir in Thai HIV-infected patients
by: Baralee Punyawudho, et al.
Published: (2018)